Back to payer list

Louisiana Department of Health · PBM: Fee-for-service · Louisiana

Louisiana Medicaid

Published Dawnzera PA criteria with a 12-month approval duration.

Medicaid FFS

Live from the coverage database

Policy Posture and UM Criteria by Indication

INDICATIONSTATUSPUBLISHED CRITERIAAUTH DURATIONEFFECTIVESOURCECONFIDENCE
Dawnzera (HAE)Published — FavorableConfirmed HAE diagnosis, minimum age 12. Continuation requires documented positive response and confirmation the patient is not concurrently on another HAE prophylaxis medication.12 months (initiation and continuation)2026-04-01Donidalorsen (Dawnzera) PA CriteriaSourced

Coverage Update YTD

2Across all sources

Treated Lives — Tryngolza (FCS)

72Patients on therapy

Ionis Brands Published

1 / 3Have a policy

Pending Policy Changes

0Next 30 days

Months since launch · illustrative

Treated Lives on Therapy — Tryngolza (FCS)

72 patients today
M1 · 6M4 · 17M8 · 32M12 · 48M18 · 61M24 · 72

50-state distribution · illustrative

Treated Lives by State — Tryngolza (FCS)

Fewer patientsMore patients

Specialty pharmacy benefit — both Ionis products are self-injected, specialty-only

72 treated lives on therapy

SD high
MEVTNHMAWAIDMTNDMNWIMINYRIORNVWYSDIAILINOHPANJCTCAUTCONEMOKYWVVAMDDEAZNMKSARTNNCSCAKOKLAMSALGAHITXFL
AI SUMMARY

Tryngolza — FCS Coverage Source Summary

State PDL criteria published for Tryngolza FCS with genetic confirmation and specialist prescribing.

Historical coverage trend

Tryngolza — FCS Lives Coverage Trend

% of lives by access status across historical snapshots.

CoveredPreferredNot coveredUnknown
100%75%50%25%0%M1M4M8M12M18M24

Covered

92%+81 pts

Preferred

78%+70 pts

Not covered

8%-12 pts

Unknown

32%+23 pts

Latest source details

Tryngolza — FCS Coverage Details

3 source views

SourcePayment TypePolicy StatusLatest Detail
MMIT SearchlightCommercialPublished — RestrictedSyndicated data reflects the most recent policy language for this indication.
FRM submissionMedicareLimited visibilityField team confirms account-level nuance not yet captured in syndicated sources.
Market Access submissionMedicaidLimited visibilityState/plan-level detail requires validation against current directories.

Brand-specific feed

Latest Updates

2 updates

MMIT Searchlight

Latest source refresh confirms no material change to published criteria this cycle.

Jun 1, 2026

FRM submission

Field notes on account-level access nuance submitted for validation.

May 18, 2026

Brand documents

Shared Documents

PDF, DOC, PNG or JPG · max 20 MB

Policy PDF

Uploaded by Market Access Team

Latest updated: Jun 1, 2026